Nisreen Akel
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Nisreen Akel's research focuses on understanding and treating bone disorders, particularly those associated with diabetes and glucocorticoid use. Her work has investigated the role of specific cellular pathways, such as chaperone-mediated autophagy, in bone mass regulation and age-related bone loss. Akel has explored therapeutic strategies, including the use of sclerostin antibodies to correct periodontal disease in diabetic mice and the development of bone-targeted inhibitors like BT-Amide for preventing glucocorticoid-induced bone loss. Her publications also include work on the effectiveness of anabolic therapies in reversing diabetic bone signatures. Akel collaborates with researchers at the University of Arkansas for Medical Sciences, including Teresita Bellido, Amy Y. Sato, Gaston Troncoso, and Betiana Perez. She has an h-index of 19, with over 2,000 citations across 41 publications.
Metrics
- h-index: 19
- Publications: 41
- Citations: 2,012
Selected Publications
- Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective <i>via</i> Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss (2024) DOI
- Sclerostin antibody corrects periodontal disease in type 2 diabetic mice (2024) DOI
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice (2024) DOI
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies (2023) DOI
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system (2023) DOI
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023) DOI
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023) DOI
- Reversal of the diabetic bone signature with anabolic therapies in mice (2023) DOI
- Loss of chaperone-mediated autophagy is associated with low vertebral cancellous bone mass (2022) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics